UC Berkeley Team to Be Awarded CRISPR Patent

The Scientist reports, “The University of California, Berkeley, and its partners in developing CRISPR gene editing will receive the patent at the heart of an intellectual property dispute between the Berkeley team and the Broad Institute and its CRISPR collaborators. On Friday (February 8), the US Patent and Trademark Office issued a “notice of allowance” for the UCB patent, indicating that it will be awarded in the coming weeks.”

Referencing client The University of California, Berkeley, Director Eldora L. Ellison, Ph.D. is quoted in the coverage, “We are pleased the patent application was allowed and that the issued patent will encompass the use of CRISPR-Cas9 technology in any cellular or non-cellular environment. We expect to see continued momentum in the expansion of UC’s CRISPR patent portfolio in the coming months.”